State Street Healthcare ETFs XLV and XBI: Cost, Performance Comparison
Published on Β· Source: finance.yahoo.com

AI Summary
Summarized by AI from the source belowThe State Street Health Care Select Sector SPDR ETF (XLV) has an expense ratio of 0.08% and a dividend yield of 1.6%, with a recent share price of approximately $163.52. In contrast, the State Street SPDR S&P Biotech ETF (XBI) has an expense ratio of 0.35% and a dividend yield of 0.4%, priced around $151.46. XLV includes large-cap stocks such as Eli Lilly (NYSE:LLY) at 15.97% and Johnson & Johnson (NYSE:JNJ) at 10.67%. This comparison of cost and performance illustrates different investment strategies, affecting investor choices and asset allocations.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Related News

Five ETFs to Watch: Shipping, Cybersecurity, Biotech, Crypto
Sep 17

Eli Lilly (LLY) Price Target Increased to $1,400, Analysts See 25% Upside
Sep 17

Tempus AI (TEM) Revenue Outlook Boosted by Morgan Stanley Insight
Sep 17

Aeluma (ALMU) Reports Q4 2026 Earnings and Market Insights
Sep 17